Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse potential of Acurox in recreational opioid users
NCT01030406Phase 2Completed
- Sponsor
- Acura Pharmaceuticals, Inc.
- Start
- Jan 2010
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxycodone + niacin in opioid use disorder (OUD), sponsored by Acura Pharmaceuticals, Inc.. Started Jan 2010; status: completed.
02
Drugs
oxycodone + niacin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01030406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01030406.